Spironolactone Tablet, Film Coated
Product Images NDC 0904-6927

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0904-6927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2c0f08d5 6d25 4525 87e0 1a340298d993 00

2c0f08d5 6d25 4525 87e0 1a340298d993 00
Description: This is a prescription drug from Major Pharmaceuticals, with the active ingredient SPIRONOLACTONE and is available in tablet form. This drug is usually prescribed to people with high blood pressure or heart disease. The package contains 100 tablets, and the usual dosage instructions, precautions and warnings are provided along with the product.*
FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 01)

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)
The text provides information on a medical study evaluating the effects of Spironolactone against Placebo. The study included a total of 822 people who took Spironolactone and 841 people who took Placebo. The results showed a p-value of less than 0,001 using Log-rank test. The study took place for a period of 42 months and possibly measured the effectiveness of Spironolactone over Placebo on a certain medical condition.*
FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)
This data contains information about various subgroups, their age, sex, race, left ventricular ejection fraction, heart failure, NYHA, diabetes, serum creatinine, creatinine clearance, potassium, Digoxin, ACE inhibitors, beta-blockers, and their heart rates. The data also includes the number of participants in each subgroup and a comparison of the effectiveness of Spironolactone and Placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.